Finally, the analysis of β3-ARs expression on tumour and microenvironmental cells (CD45− gated cells) revealed a higher β3-ARs expression in samples derived from metastatic patients, with a significant statistical difference indicating a possible involvement of β3-ARs in tumour aggressiveness (Figure 5C). This evidence concerns the gene PTPRC and neoplasm.